$1.1999
0.0199[1.69%]
At close: Apr 25
$1.1999
0[0.00%]
After Hours: 4:56PM EDT
Ocugen Stock (NASDAQ:OCGN), Analyst Ratings, Price Targets, Predictions
Ocugen Inc has a consensus price target of $6, established from looking at the 21 latest analyst ratings. The last 3 analyst ratings were released from Chardan Capital, HC Wainwright & Co., and HC Wainwright & Co. on April 22, 2024, April 3, 2024, and February 22, 2024. With an average price target of $6.33 between Chardan Capital, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 427.82% upside for Ocugen Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Chardan Capital
HC Wainwright & Co.
Cantor Fitzgerald
Mizuho
Roth Capital
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Ocugen
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/22/2024 | OCGN | Buy Now | Ocugen | $1.20 | 316.7% | Chardan Capital | Daniil Gataulin | $4 → $5 | Maintains | Buy | Get Alert |
| 04/03/2024 | OCGN | Buy Now | Ocugen | $1.20 | 483.38% | HC Wainwright & Co. | Swayampakula Ramakanth | → $7 | Reiterates | Buy → Buy | Get Alert |
| 02/22/2024 | OCGN | Buy Now | Ocugen | $1.20 | 483.38% | HC Wainwright & Co. | Swayampakula Ramakanth | → $7 | Reiterates | Buy → Buy | Get Alert |
| 01/24/2024 | OCGN | Buy Now | Ocugen | $1.20 | 483.38% | HC Wainwright & Co. | Swayampakula Ramakanth | $5 → $7 | Maintains | Buy | Get Alert |
| 08/31/2023 | OCGN | Buy Now | Ocugen | $1.20 | 66.68% | Cantor Fitzgerald | Jennifer Kim | $2.5 → $2 | Maintains | Overweight | Get Alert |
| 08/23/2023 | OCGN | Buy Now | Ocugen | $1.20 | 316.7% | HC Wainwright & Co. | Swayampakula Ramakanth | → $5 | Reiterates | Buy → Buy | Get Alert |
| 05/08/2023 | OCGN | Buy Now | Ocugen | $1.20 | 233.36% | Chardan Capital | Daniil Gataulin | $3.5 → $4 | Maintains | Buy | Get Alert |
| 04/17/2023 | OCGN | Buy Now | Ocugen | $1.20 | 316.7% | HC Wainwright & Co. | Swayampakula Ramakanth | → $5 | Reiterates | → Buy | Get Alert |
| 04/14/2023 | OCGN | Buy Now | Ocugen | $1.20 | 191.69% | Chardan Capital | Daniil Gataulin | → $3.5 | Maintains | Buy | Get Alert |
| 03/01/2023 | OCGN | Buy Now | Ocugen | $1.20 | 191.69% | Chardan Capital | Daniil Gataulin | → $3.5 | Upgrade | Neutral → Buy | Get Alert |
| 03/01/2023 | OCGN | Buy Now | Ocugen | $1.20 | 150.02% | Mizuho | Uy Ear | $5 → $3 | Maintains | Buy | Get Alert |
| 03/01/2023 | OCGN | Buy Now | Ocugen | $1.20 | 316.7% | HC Wainwright & Co. | Swayampakula Ramakanth | $6 → $5 | Reiterates | → Buy | Get Alert |
| 08/23/2022 | OCGN | Buy Now | Ocugen | $1.20 | 316.7% | Mizuho | Uy Ear | → $5 | Initiates | → Buy | Get Alert |
| 08/15/2022 | OCGN | Buy Now | Ocugen | $1.20 | 400.04% | HC Wainwright & Co. | Swayampakula Ramakanth | $7 → $6 | Maintains | Buy | Get Alert |
| 06/15/2022 | OCGN | Buy Now | Ocugen | $1.20 | 566.72% | Roth Capital | Jonathan Aschoff | → $8 | Reinstates | → Buy | Get Alert |
| 06/02/2022 | OCGN | Buy Now | Ocugen | $1.20 | 275.03% | Cantor Fitzgerald | Jennifer Kim | → $4.5 | Initiates | → Overweight | Get Alert |
| 05/12/2022 | OCGN | Buy Now | Ocugen | $1.20 | 483.38% | HC Wainwright & Co. | Swayampakula Ramakanth | $8 → $7 | Maintains | Buy | Get Alert |
| 02/28/2022 | OCGN | Buy Now | Ocugen | $1.20 | 566.72% | HC Wainwright & Co. | Swayampakula Ramakanth | $10 → $8 | Maintains | Buy | Get Alert |
| 06/11/2021 | OCGN | Buy Now | Ocugen | $1.20 | 400.04% | Roth Capital | Zegbeh Jallah | — | Downgrade | Buy → Neutral | Get Alert |
FAQ
What is the target price for Ocugen (OCGN)?
The latest price target for Ocugen (NASDAQ: OCGN) was reported by Chardan Capital on April 22, 2024. The analyst firm set a price target for $5.00 expecting OCGN to rise to within 12 months (a possible 316.70% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Ocugen (OCGN)?
The latest analyst rating for Ocugen (NASDAQ: OCGN) was provided by Chardan Capital, and Ocugen maintained their buy rating.
When was the last upgrade for Ocugen (OCGN)?
The last upgrade for Ocugen Inc happened on March 1, 2023 when Chardan Capital raised their price target to $3.5. Chardan Capital previously had a neutral for Ocugen Inc.
When was the last downgrade for Ocugen (OCGN)?
The last downgrade for Ocugen Inc happened on June 11, 2021 when Roth Capital changed their price target from $10 to $6 for Ocugen Inc.
When is the next analyst rating going to be posted or updated for Ocugen (OCGN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ocugen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ocugen was filed on April 22, 2024 so you should expect the next rating to be made available sometime around April 22, 2025.
Is the Analyst Rating Ocugen (OCGN) correct?
While ratings are subjective and will change, the latest Ocugen (OCGN) rating was a maintained with a price target of $4.00 to $5.00. The current price Ocugen (OCGN) is trading at is $1.20, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.